Generative AI drug discovery hub Converge Bio raises $5.5M to understand the ‘language of biology’ Posted on : Nov 20 - 2024

Drug discovery startup Converge Bio Inc. said today it has closed on a $5.5 million seed round of funding to help biotech and pharmaceutical companies develop more effective drugs at faster speeds by leveraging generative artificial intelligence. View More